본문 바로가기

Signing of Investment Contract for Samsung Biologics' Third Campus
  • Date Created : 2025-11-28
  • Number of Views : 55
(251128)삼성바이오로직스 투자계약 체결(3256)
(251128)삼성바이오로직스 투자계약 체결(3257)
(251128)삼성바이오로직스 투자계약 체결(3258)
(251128)삼성바이오로직스 투자계약 체결(3260)
(251128)삼성바이오로직스 투자계약 체결(3262)
(251128)삼성바이오로직스 투자계약 체결(3263)
(251128)삼성바이오로직스 투자계약 체결(3264)
(251128)삼성바이오로직스 투자계약 체결(3265)
(251128)삼성바이오로직스 투자계약 체결(3256)
(251128)삼성바이오로직스 투자계약 체결(3257)
(251128)삼성바이오로직스 투자계약 체결(3258)
(251128)삼성바이오로직스 투자계약 체결(3260)
(251128)삼성바이오로직스 투자계약 체결(3262)
(251128)삼성바이오로직스 투자계약 체결(3263)
(251128)삼성바이오로직스 투자계약 체결(3264)
(251128)삼성바이오로직스 투자계약 체결(3265)

On November 28, 2025 (Friday), IFEZ signed a land sale contract with Samsung Biologics at Incheon Metropolitan City Hall for an industrial facility site (187,427㎡) in the Advanced Industrial Cluster (C) of Songdo International City's 11th district. This contract aims to establish a bio village for next-generation biopharmaceutical research, development, and manufacturing, including cell and gene therapies. The total project investment is estimated at 7 trillion KRW, with the facility expected to create over 4,000 new jobs by 2034. This initiative strengthens the bio-cluster's competitive edge by attracting anchor companies to Songdo's 11th district.